Cormorant Asset Management, LP Q3 2016 Filing
Filed November 14, 2016
Portfolio Value
$906.8B
Holdings
84
Report Date
Q3 2016
Filing Type
13F-HR
All Holdings (84 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —ALDER BIOPHARMACEUTICALS INC | 1,689,071 | $55.4B | 6.10% | |
| 2 | NVROEURNEVRO CORP | 491,044 | $51.3B | 5.65% | |
| 3 | TBPHTHERAVANCE BIOPHARMA INC | 1,118,372 | $40.5B | 4.47% | |
| 4 | NERVGBPMINERVA NEUROSCIENCES INC | 2,800,000 | $39.5B | 4.36% | |
| 5 | —PROTEOSTASIS THERAPEUTICS IN | 2,350,000 | $36.6B | 4.04% | |
| 6 | CLSDUSDCLEARSIDE BIOMEDICAL INC | 1,988,208 | $34.5B | 3.80% | |
| 7 | EGRXEAGLE PHARMACEUTICALS INC | 455,995 | $31.9B | 3.52% | |
| 8 | HRTXHERON THERAPEUTICS INC | 1,771,263 | $30.5B | 3.37% | |
| 9 | ARDXARDELYX INC | 2,071,964 | $26.8B | 2.96% | |
| 10 | —MYOKARDIA INC | 1,605,790 | $26.2B | 2.89% | |
| 11 | CLVSEURCLOVIS ONCOLOGY INC | 650,000 | $23.4B | 2.58% | |
| 12 | ACRSACLARIS THERAPEUTICS INC | 901,286 | $23.1B | 2.55% | |
| 13 | —QUOTIENT LTD | 2,787,717 | $21.8B | 2.40% | |
| 14 | GLPGGALAPAGOS NV | 334,044 | $21.4B | 2.36% | |
| 15 | MGNXMACROGENICS INC | 707,978 | $21.2B | 2.34% | |
| 16 | NBIXNEUROCRINE BIOSCIENCES INC | 398,301 | $20.2B | 2.22% | |
| 17 | OMEROMEROS CORP | 1,695,000 | $18.9B | 2.09% | |
| 18 | PTGXPROTAGONIST THERAPEUTICS INC | 800,000 | $16.9B | 1.86% | |
| 19 | WVEWAVE LIFE SCIENCES LTD | 507,907 | $16.5B | 1.82% | |
| 20 | SRNESORRENTO THERAPEUTICS INC | 2,121,013 | $16.4B | 1.81% | |
| 21 | CHRSCOHERUS BIOSCIENCES INC | 576,106 | $15.4B | 1.70% | |
| 22 | —CHINA BIOLOGIC PRODS INC | 112,867 | $14.1B | 1.55% | |
| 23 | CRBPEURCORBUS PHARMACEUTICALS HLDGS | 2,000,000 | $13.6B | 1.50% | |
| 24 | —PORTOLA PHARMACEUTICALS INC | 596,000 | $13.5B | 1.49% | |
| 25 | CLLSCELLECTIS S A | 498,117 | $12.0B | 1.32% | |
| 26 | AGENEURAGENUS INC | 1,578,106 | $11.3B | 1.25% | |
| 27 | —INVUITY INC | 767,466 | $10.5B | 1.16% | |
| 28 | —ADVAXIS INC | 920,915 | $9.8B | 1.09% | |
| 29 | —GEMPHIRE THERAPEUTICS INC | 900,000 | $9.8B | 1.08% | |
| 30 | —CONTRAFECT CORP | 3,840,966 | $9.5B | 1.05% | |
| 31 | —INC RESH HLDGS INC | 200,000 | $8.9B | 0.98% | |
| 32 | 2L9BLUEPRINT MEDICINES CORP | 298,870 | $8.9B | 0.98% | |
| 33 | COLLCOLLEGIUM PHARMACEUTICAL INC | 455,515 | $8.8B | 0.97% | |
| 34 | DC4DEXCOM INC | 100,000 | $8.8B | 0.97% | |
| 35 | ALNYALNYLAM PHARMACEUTICALS INC | 126,120 | $8.5B | 0.94% | |
| 36 | —ACHILLION PHARMACEUTICALS | 1,006,128 | $8.2B | 0.90% | |
| 37 | —AUDENTES THERAPEUTICS INC | 449,660 | $8.0B | 0.88% | |
| 38 | EBSEMERGENT BIOSOLUTIONS INC | 250,000 | $7.9B | 0.87% | |
| 39 | RAREULTRAGENYX PHARMACEUTICAL IN | 110,842 | $7.9B | 0.87% | |
| 40 | ARRYEURARRAY BIOPHARMA INC | 1,150,000 | $7.8B | 0.86% | |
| 41 | FLGTFULGENT GENETICS INC | 800,000 | $7.4B | 0.81% | |
| 42 | —FORWARD PHARMA A/S | 339,175 | $7.1B | 0.79% | |
| 43 | GBYSANGAMO BIOSCIENCES INC | 1,402,331 | $6.5B | 0.72% | |
| 44 | —CURIS INC | 2,410,900 | $6.3B | 0.69% | |
| 45 | —ZYNERBA PHARMACEUTICALS INC | 480,501 | $6.3B | 0.69% | |
| 46 | SCTLRECRO PHARMA INC | 669,239 | $5.9B | 0.65% | |
| 47 | CTMXCYTOMX THERAPEUTICS INC | 371,636 | $5.8B | 0.64% | |
| 48 | —DERMIRA INC | 172,083 | $5.8B | 0.64% | |
| 49 | —PFENEX INC | 632,559 | $5.7B | 0.62% | |
| 50 | —AVEXIS INC | 131,858 | $5.4B | 0.60% | |
| 51 | —CATABASIS PHARMACEUTICALS IN | 800,000 | $4.9B | 0.54% | |
| 52 | —INTEC PHARMA LTD JERUSALEM | 809,804 | $4.8B | 0.53% | |
| 53 | XLRNACCELERON PHARMA INC | 127,451 | $4.6B | 0.51% | |
| 54 | —ONCOBIOLOGICS INC | 1,027,216 | $4.4B | 0.48% | |
| 55 | RIGLUSDRIGEL PHARMACEUTICALS INC | 1,155,600 | $4.2B | 0.47% | |
| 56 | —LION BIOTECHNOLOGIES INC | 505,941 | $4.2B | 0.46% | |
| 57 | ATRAGBXATARA BIOTHERAPEUTICS INC | 186,460 | $4.0B | 0.44% | |
| 58 | —AGILE THERAPEUTICS INC | 563,880 | $3.9B | 0.43% | |
| 59 | SNDXSYNDAX PHARMACEUTICALS INC | 240,403 | $3.6B | 0.40% | |
| 60 | CRVSCORVUS PHARMACEUTICALS INC | 214,132 | $3.5B | 0.39% | |
| 61 | —LIPOCINE INC NEW | 751,296 | $3.4B | 0.37% | |
| 62 | —IMMUNE DESIGN CORP | 432,990 | $3.3B | 0.36% | |
| 63 | —APTOSE BIOSCIENCES INC | 990,579 | $2.2B | 0.25% | |
| 64 | RGNXREGENXBIO INC | 156,741 | $2.2B | 0.24% | |
| 65 | GLYCEURGLYCOMIMETICS INC | 287,031 | $2.1B | 0.23% | |
| 66 | —AQUINOX PHARMACEUTICALS INC | 151,838 | $2.0B | 0.22% | |
| 67 | —CELYAD SA | 75,920 | $1.8B | 0.20% | |
| 68 | —EPIZYME INC | 159,513 | $1.6B | 0.17% | |
| 69 | ASNDASCENDIS PHARMA A S | 62,254 | $1.3B | 0.14% | |
| 70 | AM6AMICUS THERAPEUTICS INC | 151,838 | $1.1B | 0.12% | |
| 71 | —AVEO PHARMACEUTICALS INC | 1,087,715 | $968.0M | 0.11% | |
| 72 | NSTGEURNANOSTRING TECHNOLOGIES INC | 40,490 | $809.0M | 0.09% | |
| 73 | —THRESHOLD PHARMACEUTICAL INC | 1,012,255 | $686.0M | 0.08% | |
| 74 | —ONCOBIOLOGICS INC | 416,666 | $500.0M | 0.06% | |
| 75 | —HTG MOLECULAR DIAGNOSTICS IN | 203,464 | $472.0M | 0.05% | |
| 76 | —GENVEC INC | 1,015,685 | $468.0M | 0.05% | |
| 77 | —NEOS THERAPEUTICS INC | 50,613 | $333.0M | 0.04% | |
| 78 | PVCTPROVECTUS BIOPHARMACEUTICALS | 2,226,961 | $221.0M | 0.02% | |
| 79 | —ONCOBIOLOGICS INC | 416,666 | $199.0M | 0.02% | |
| 80 | ADAPYADAPTIMMUNE THERAPEUTICS PLC | 25,307 | $178.0M | 0.02% | |
| 81 | —APPLIED GENETIC TECHNOL CORP | 17,321 | $169.0M | 0.02% | |
| 82 | —CELLECTAR BIOSCIENCES INC | 53,649 | $145.0M | 0.02% | |
| 83 | —PROVECTUS BIOPHARMACEUTICALS | 2,200,000 | $114.0M | 0.01% | |
| 84 | —CELLECTAR BIOSCIENCES INC | 52,999 | $13.0M | 0.00% |